1. Synthesis of a Novel Siliconized Analog of Clofibrate (Silafibrate) and Comparison of their Anti-inflammatory Activities.
- Author
-
Ziaee, Mojtaba, Saminia, Morteza, Bolourtchian, Mohammad, Ghaffarzadeh, Mohammad, Ahmadi, Maryam, Egbal, Mohammad Ali, Khorrami, Arash, Andalib, Sina, Maleki-Dizaji, Nasrin, and Garjani, Alireza
- Subjects
- *
ANTI-inflammatory agents , *DRUG development , *ANTILIPEMIC agents , *SILICON , *PEROXISOMES , *CELL adhesion molecules - Abstract
Fibrates, as hypolipidemic drugs known as agonists of peroxisome proliferator-activated receptors, diminish inflammatory responses. Studies have shown that incorporation of a silicon atom into a drug structure improves its pharmacological potency, modifies its selectivity toward a given target, or changes its metabolic rate, in addition to increasing the lipophilicity of the compounds. A siliconized analog of clofibrate, ethyl-2-methyl-2-(4-(trimethylsilyl)phenoxy)propionate was synthesized, whereby the chlorine atom in the phenoxy ring was replaced by a trimethylsilyl group. The anti-inflammatory effects of the siliconized analog (silafibrate) were evaluated in an air-pouch model of inflammation and compared with those of clofibrate. Oral administration of both drugs produced a significant anti-inflammatory action by reducing carrageenan induced pouch leukocyte recruitment, exudates production, and granulated tissue weight. The silicon isostere of clofibrate has improved anti-inflammatory properties. [ABSTRACT FROM AUTHOR]
- Published
- 2012